These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Adjuvant use of interferon alpha 2b is not justified in patients with stage IIb/III melanoma. Bajetta E Nat Clin Pract Oncol; 2008 Jan; 5(1):4-5. PubMed ID: 18043604 [No Abstract] [Full Text] [Related]
10. Autoimmune phenomena as prognostic markers of response to adjuvant interferon therapy for melanoma. Puente Vázquez J; González Larriba JL Clin Transl Oncol; 2007 Mar; 9(3):125-6. PubMed ID: 17403622 [No Abstract] [Full Text] [Related]
11. Interferon for melanoma. Richtig E; Langmann G Ophthalmology; 2010 Sep; 117(9):1861. PubMed ID: 20816255 [No Abstract] [Full Text] [Related]
12. How does interferon work? Does it even matter? Sondak VK Cancer; 2002 Sep; 95(5):947-9. PubMed ID: 12209676 [No Abstract] [Full Text] [Related]
15. Peginterferon alph-2b (Sylatron) for melanoma. Med Lett Drugs Ther; 2011 Sep; 53(1373):76. PubMed ID: 21921873 [No Abstract] [Full Text] [Related]
16. Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial. Hansson J; Aamdal S; Bastholt L; Brandberg Y; Hernberg M; Nilsson B; Stierner U; von der Maase H; Lancet Oncol; 2011 Feb; 12(2):144-52. PubMed ID: 21256809 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial. Hauschild A; Weichenthal M; Rass K; Linse R; Berking C; Böttjer J; Vogt T; Spieth K; Eigentler T; Brockmeyer NH; Stein A; Näher H; Schadendorf D; Mohr P; Kaatz M; Tronnier M; Hein R; Schuler G; Egberts F; Garbe C J Clin Oncol; 2010 Feb; 28(5):841-6. PubMed ID: 20048184 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose? Schuchter LM J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612 [No Abstract] [Full Text] [Related]
19. Interferon as adjuvant treatment for melanoma. Wheatley K; Ives N; Hancock B; Gore M Lancet; 2002 Sep; 360(9336):878. PubMed ID: 12243953 [No Abstract] [Full Text] [Related]
20. Update on the role of adjuvant interferon for high risk melanoma. Agarwala SS; Kirkwood JM Forum (Genova); 2000; 10(3):230-9. PubMed ID: 11007931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]